Kurzporträt
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Biologics and Drug Delivery - Services and License
47,8
%
| 5 | 26,4 % | 11 | 47,8 % | +110,83 % |
Functional Neurosurgery Navigation and Therapy - Disposable Products
31,7
%
| 8 | 36,9 % | 8 | 31,7 % | +0,03 % |
Biologics and Drug Delivery - Disposable Products
9,0
%
| 4 | 18,0 % | 2 | 9,0 % | -41,63 % |
Capital Equipment and Software - Services
4,1
%
| 1 | 3,9 % | 1 | 4,1 % | +22,39 % |
Functional Neurosurgery Navigation and Therapy - Services
3,9
%
| 2 | 7,5 % | 1 | 3,9 % | -39,43 % |
Capital Equipment and Software - Systems and Software Products
3,6
%
| 2 | 7,4 % | 1 | 3,6 % | -43,12 % |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 21 | 100,0 % | 24 | 100,0 % | +16,56 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Joseph Burnett
CEO | Chief Executive Officer | 47 | 07.11.17 |
Director of Finance/CFO | 39 | 29.09.20 | |
Mazin Sabra
COO | Chief Operating Officer | 44 | 10.10.22 |
Caroline Corner
IRC | Investor Relations Contact | - | - |
Jeremy Stigall
PRN | Corporate Officer/Principal | 41 | 01.07.20 |
General Counsel | - | 05.04.21 | |
Sales & Marketing | - | 01.11.19 | |
General Counsel | - | - | |
Robert Korn
SAM | Sales & Marketing | 58 | 12.11.12 |
Chris Yelley
PRN | Corporate Officer/Principal | - | 01.01.12 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
B. Johnson
BRD | Director/Board Member | 72 | 01.09.19 |
Lynnette Fallon
BRD | Director/Board Member | 64 | 15.07.21 |
R. Fletcher
CHM | Chairman | 78 | 09.05.17 |
Pascal Girin
BRD | Director/Board Member | 64 | 03.09.14 |
Timothy Richards
BRD | Director/Board Member | 66 | 10.03.14 |
Joseph Burnett
CEO | Chief Executive Officer | 47 | 07.11.17 |
Matthew Klein
BRD | Director/Board Member | 52 | 16.04.20 |
Linda Liau
BRD | Director/Board Member | 57 | 02.11.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 27 420 327 | 25 250 110 ( 92,09 %) | 0 | 92,09 % |
Unternehmenskontakt
Clearpoint Neuro, Inc.
120 South Sierra Avenue Suite 100
92075, Solana Beach
+
http://www.clearpointneuro.comSektor
Umsatz nach Geschäftsbereich
% 1. Jan. | Kap. | |
---|---|---|
+4,64 % | 208 Mrd. | |
+8,99 % | 182 Mrd. | |
+29,83 % | 155 Mrd. | |
+35,17 % | 115 Mrd. | |
+2,55 % | 66,52 Mrd. | |
+15,06 % | 53,93 Mrd. | |
-6,47 % | 46,26 Mrd. | |
-2,14 % | 38,22 Mrd. | |
+6,88 % | 36,6 Mrd. |